Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05160259Active Not Recruiting

Radial Visualization of the Foramen Arcuale Atlantis

Role: lead

NCT04613180Phase 4Unknown

Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis

Role: lead

NCT04611412Unknown

Determination of Risk Factors for the Development of Obesity and Hypertension in Children According to Perinatal Programming of Metabolism

Role: lead

NCT04605835Unknown

Ultrasonic Visualization of Obstructive Uropathies in Children

Role: lead

NCT04599621Recruiting

Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome

Role: lead

NCT04562259Active Not Recruiting

Verification of Kimmerle's Anomaly by X-ray Methods of Research

Role: lead

All 6 trials loaded